GDx VCC Nerve Fiber Analyzer

While the three most common tests for glaucoma (IOP evaluation, visual field analysis, and optic nerve evaluation) are useful, they often do not detect glaucoma early enough.

The GDx VCC is the only glaucoma detection technology available that directly and objectively evaluates the nerve fiber layer of the eye. This test is comfortable, does not require drops or pupil dilation and provides results for both eyes within 3 minutes.

Breakthrough Technology

Now . . . early, accurate detection of retinal nerve fiber layer (RNFL) damage in just 3 minutes with breakthrough scanning laser ophthalmoscope technology that measures the extent of glaucoma damage where it occurs -- at the RNFL.

Early diagnosis

• Retinal nerve fiber layer damage is present up to 6 years before visual field damage.

True diagnosis

• Measurements are compared to a normative database to provide quick, easy and objective analysis.

• Test parameters do not rely on questionable risk factors for glaucoma.

• Nerve fiber analysis with polarimetry shows early damage caused by glaucoma.

• Optic nerve head analysis can’t always differentiate anatomical cupping from cupping resulting from glaucoma.

Fast diagnosis

• Less than 1 second to image
• Exam in just minutes
• No dilation required

Continual diagnosis and follow-up

• Typical image reproducibility of better than 15 µm allows precise, accurate follow-up of change over time.

• Serial analysis printout clearly shows specific areas of disease progression.

Pachymeter SONOGAGE
CORNED-GAGE PLUS

Comeo-Gage Plus is the only pachymeter which has kept pace with evolving retractive technology. Excimer laser, automated lamellar keratoplasty and radial keratotomy each have specific pachometric requirement - Comeo-Gage Plus meets these requirements and more: astigmatic keratometry, monitoring Fuch's dystophy, monitoring corneal edema, monitoring daily and extended contact lens wearers, and monitoring early failure of corneal grafts.

Call for more information . . .

Click here to browse the State Directory to find an MGS representative in your local area.

Ocular Blood Flow Analyzer

The Ocular Blood Flow Analyzer (BFA) assists in the management of glaucoma and detection of other circulatory abnormalities associated with diabetes and retinal and carotid disorders.

Clinical benefits of the BFA

• Identify low and normal-tension glaucoma suspects who tend to have significantly lower ocular blood flow (OBF) than normal. Low OBFs may put any part of the eye at risk.

Glaucoma is just one disease where abnormal OBF is likely to be a major risk factor.

• Identify vascular disorders, such as internal carotid stenosis, by finding a differential of greater than 4 microliters per second between eyes although the IOPs between eyes may be similar.

• Monitor ocular and systemic drugs – such as beta and calcium-channel blockers -- that have the potential to modify OBF.

The Ocular BFA is a clinically proven test that increases early diagnosis of low and normal-tension glaucoma.

The BFA is now recognized as an important diagnostic measurement for your patient. The BFA records pulsatile ocular blood flow data, providing significant new information about the vascular network in the eye.

Studies have indicated that blood flow is significantly compromised in many eyes with normal-tension glaucoma, with and without field loss. The BFA improves your ability to monitor and manage your patients.

In one automatic, 10-second measurement, information is captured and displayed on the screen. Data is printed on a concise patient record.

Numeric and graphic data in one test:

• IOP
• Pulse amplitude
• Systolic and diastolic cycles
• Ocular Blood Flow (microliters/sec)

The BFA's pneumotonometer has been shown to have greater accuracy in IOP measurement than traditional Goldmann. Because the pneumotonometer has a smaller applanation probe, the IOP findings are less influenced by variations in corneal thickness.